The page is the record's research on the issuer — no analyst, no rating, no view.

FORMYCON AG (FYB) — research page

DE · de-cm-kg/XETRA/FYB · as of 2026-11-06

Identity and listing

FORMYCON AG is listed on Xetra under ticker FYB. Its ISIN is DE000A1EWVY8 and its LEI is 39120005TZ76GQOY8Z19. The security type is Corporate and the segment is DEUTSCHLAND. The sector is not on the record, as the Xetra instruments file carries index membership and not a sector classification. The jurisdiction is Germany (Handelsregister HRB). The listing status is listed, not halted.

fieldvaluesource · read date
nameFORMYCON AGsource · 2026-11-06
exchangeXetrasource · 2026-11-06
tickerFYBsource · 2026-11-06
ISINDE000A1EWVY8source · 2026-11-06
LEI39120005TZ76GQOY8Z19source · 2026-11-09
security typeCorporatesource · 2026-11-06
segmentDEUTSCHLANDsource · 2026-11-06
sectornot on the record
jurisdictionGermany (Handelsregister HRB)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 27 filings in the twelve months to 2026-11-06, across 13 filing days. By type, the filings are 2 ad hoc, 18 corporate news, 5 newswire releases and 2 results. The median gap between filing days is 9.5 days. The latest filing is dated 2026-11-06, is of type corporate news, and is 0 days before the record date. The median cadence gap for Xetra is 22.8 days across 419 issuers, and the median filings count is 6. The median latency for Xetra is 5.5 days. The sector peer figures are not on the record for DE.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer279.50
exchange median: Xetra (419 issuers)622.85.5
datetypecategoryfiling
2026-11-06corporate_newscorporateFormycon maintains 2026 guidance for revenue, EBITDA and working capital, revises adjusted EBITDA and reassesses FYB201 and FYB202 | Corporate - EQS News
2026-11-06ad_hocad-hocFormycon AG recognizes non-cash impairments on FYB201 and FYB202 and revises its guidance for adjusted EBITDA | Ad-hoc - EQS News
2026-11-05corporate_newscorporateFormycon maintains 2026 guidance for revenue, EBITDA and working capital, revises adjusted EBITDA and reassesses FYB201 and FYB202 | Corporate - EQS News
2026-11-05corporate_newscorporateFormycon invites to conference call on 2026 nine-month results and announces participation in international investor conferences | Corporate - EQS News
2026-11-05corporate_newscorporate-newsFormycon lädt zur Telefonkonferenz zum Neunmonatsergebnis 2026 ein und gibt Teilnahme an internationalen Investorenkonferenzen bekannt | Corporate - EQS News

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record. The register carries the annual report link only. No auditor changes are on the record, as the market's lifecycle type map is not yet in place.

Events and halts

The listing, delisting, name change, domicile change and segment move lines are not on the record, as the market's lifecycle type map is not yet in place. The halt flag shows listed, not halted.

Orderability

The outcome is determinable for all three client categories: Professionelle Kunden, Privatkunden and Geeignete Gegenparteien. Each carries signal ACM-200. The rule version is acm-68000/de/mifid-ii-product-governance-produkt-berwachung/r1, and the chapter is as of 2026-11-04.

client categoryoutcome
Geeignete GegenparteienACM-200
PrivatkundenACM-200
Professionelle KundenACM-200

rule acm-68000/de/mifid-ii-product-governance-produkt-berwachung/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names 7 research houses: Berenberg, First Berlin, HCW, Jefferies, Keppler Cheuvreux, mwb Research and Oddo BHF.

research houseanalystsource · read date
BerenbergChristian Ehmannissuer page · 2026-11-12
First BerlinSimon Scholesissuer page · 2026-11-12
HCWYi Chenissuer page · 2026-11-12
JefferiesShan Hamaissuer page · 2026-11-12
Keppler CheuvreuxNicolas Pauillacissuer page · 2026-11-12
mwb ResearchAlexander Zienkowiczissuer page · 2026-11-12
Oddo BHFMartial Descouturesissuer page · 2026-11-12

Open research

The record holds 1 openly published research note, from Metzler Capital Markets, dated 2019-12-05.

datepublishernotekind
2019-12-05Metzler Capital MarketsCatching the next wave of blockbuster biosimilarsissuer-sponsored

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market is not vintage-sealed. No issuer years are sealed, the market's earliest sealed date is null, and the live record began null.

Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.xetra.com/xetra-en/instruments/shares/list-of-tradable-shares (identity.exchange)
10.2
https://api.gleif.org/api/v1/lei-records/39120005TZ76GQOY8Z19 (identity.jurisdiction)
10.3
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.4
https://mcp.de-cm-kg.ai/events/XETRA/FYB (the disclosure lines)
10.5
https://www.cashmarket.deutsche-boerse.com/cash-en/Stay-Informed/current-regulatory-topics/mifid-ii-releases/4086638!suspension-list (the halt flag)
10.6
https://mcp.de-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://www.formycon.com/en/investor-relations/formycon-shares/ (coverage)
10.8
https://www.formycon.com/wp-content/uploads/2022/07/2019.12.05_Metzler-Capital-Markets_Initialstudie_FYB.pdf (open research)
10.9
https://mcp.de-cm-kg.ai/record/XETRA/FYB (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"DE000A1EWVY8"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:4ed3435b694fded3.